Protalix BioTherapeutics (PLX) Enterprise Value (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.76% |
| Dec 31, 2025 | 44.52% |
| Sep 30, 2025 | 12.06% |
| Jun 30, 2025 | 3.87% |
| Mar 31, 2025 | -130.54% |
| Dec 31, 2024 | 45.02% |
| Sep 30, 2024 | 39.13% |
| Jun 30, 2024 | 7.13% |
| Mar 31, 2024 | -8.81% |
| Dec 31, 2023 | -8.75% |
| Sep 30, 2023 | 14.96% |
| Jun 30, 2023 | -45.85% |
| Mar 31, 2023 | -48.94% |
| Dec 31, 2022 | -6.58% |
| Sep 30, 2022 | 27.17% |
| Jun 30, 2022 | 13.19% |
| Mar 31, 2022 | 15.56% |
| Dec 31, 2021 | 19.88% |
| Sep 30, 2021 | 36.76% |
| Jun 30, 2021 | -9.24% |
| Mar 31, 2021 | -239.98% |
| Dec 31, 2020 | 49.83% |
| Sep 30, 2020 | -18.01% |
| Jun 30, 2020 | 4.59% |
| Mar 31, 2020 | -106.13% |
| Dec 31, 2019 | 17.02% |
| Sep 30, 2019 | 14.56% |
| Jun 30, 2019 | 17.35% |
| Mar 31, 2019 | 19.69% |
| Dec 31, 2018 | 9.70% |
| Sep 30, 2018 | -47.80% |
| Jun 30, 2018 | 31.44% |
| Mar 31, 2018 | 19.24% |
| Dec 31, 2017 | -52.81% |
| Sep 30, 2017 | 3.04% |
| Jun 30, 2017 | 28.08% |
| Mar 31, 2017 | 24.12% |
| Dec 31, 2016 | -23.31% |
| Sep 30, 2016 | 6.05% |
| Jun 30, 2016 | 18.06% |
| Mar 31, 2016 | 12.71% |
| Dec 31, 2015 | -123.00% |
| Sep 30, 2015 | 20.79% |
| Jun 30, 2015 | 9.84% |
| Mar 31, 2015 | 12.43% |
| Mar 31, 2014 | 10.08% |
| Dec 31, 2013 | 5.47% |
| Sep 30, 2013 | -175.91% |
| Jun 30, 2013 | 20.88% |
| Mar 31, 2013 | 19.53% |
| Dec 31, 2012 | -3.62% |
| Sep 30, 2012 | 15.29% |
| Jun 30, 2012 | -29.99% |
| Mar 31, 2012 | -68.90% |
| Dec 31, 2011 | 21.88% |
| Sep 30, 2011 | 21.54% |
| Jun 30, 2011 | 12.29% |
| Mar 31, 2011 | -39.91% |
| Dec 31, 2010 | 19.15% |
| Sep 30, 2010 | 19.21% |